Announced
Completed
Synopsis
Ingersoll Rand, a global provider of mission-critical flow creation and industrial solutions, completed the acquisition of ILC Dover, a company specializing in the design and production of highly innovative solutions for biopharmaceutical, pharmaceutical, and medical device markets, from New Mountain Capital, a leading growth-oriented investment firm, for $2.325bn. “This acquisition is the next phase of our long-term vision to expand into higher-growth end markets like life sciences. I am incredibly excited to partner with Corey and the outstanding team at ILC, whom we’ve admired for their innovative products and decades of experience in life sciences, to enhance our presence in key workflows and applications,” Vicente Reynal, Ingersoll Rand Chairman and CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.